Search

Your search keyword '"Mark K. Slifka"' showing total 185 results

Search Constraints

Start Over You searched for: Author "Mark K. Slifka" Remove constraint Author: "Mark K. Slifka"
185 results on '"Mark K. Slifka"'

Search Results

1. Infant diarrheal disease in rhesus macaques impedes microbiome maturation and is linked to uncultured Campylobacter species

2. Campylobacter vaccination reduces diarrheal disease and infant growth stunting among rhesus macaques

Catalog

Books, media, physical & digital resources

3. State-of-the-Science of human papillomavirus vaccination in women with human immunodeficiency Virus: Summary of a scientific workshop

4. Reduced infant rhesus macaque growth rates due to environmental enteric dysfunction and association with histopathology in the large intestine

5. Taxonomic and Functional Shifts in the Perinatal Gut Microbiome of Rhesus Macaques

6. Immunogenicity of Pfizer mRNA COVID-19 Vaccination Followed by J&J Adenovirus COVID-19 Vaccination in Two Patients with Chronic Lymphocytic Leukemia

7. Longitudinal Profiling of the Macaque Vaginal Microbiome Reveals Similarities to Diverse Human Vaginal Communities

8. Plasma cell survival in the absence of B cell memory

9. Lymphatic Vessels Balance Viral Dissemination and Immune Activation following Cutaneous Viral Infection

10. Role of Multivalency and Antigenic Threshold in Generating Protective Antibody Responses

11. Retrospective Analysis of Monkeypox Infection

12. Serologic Evidence for Novel Poxvirus in Endangered Red Colobus Monkeys, Western Uganda

13. Therapeutic neutralizing monoclonal antibody administration protects against lethal yellow fever virus infection

14. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)–Specific Memory B Cells From Individuals With Diverse Disease Severities Recognize SARS-CoV-2 Variants of Concern

15. Multiethnic genome-wide and HLA association study of total serum IgE level

16. Growth faltering regardless of chronic diarrhea is associated with mucosal immune dysfunction and microbial dysbiosis in the gut lumen

17. Active Circulation of Corynebacterium ulcerans among Nonhuman Primates

18. Cellular and Humoral Immune Responses in Mice Immunized with Vaccinia Virus Expressing the SARS-CoV-2 Spike Protein

19. Therapeutic neutralizing monoclonal antibody administration protects against lethal Yellow Fever infection

20. Incidence of Tetanus and Diphtheria in Relation to Adult Vaccination Schedules

21. Development of a next-generation chikungunya virus vaccine based on the HydroVax platform

22. The secreted protein Cowpox Virus 14 contributes to viral virulence and immune evasion by engaging Fc-gamma-receptors

23. Cellular and humoral Immune response to mRNA COVID-19 vaccination in subjects with chronic lymphocytic leukemia

24. Signaling sphingolipids are biomarkers for atopic dermatitis prone to disseminated viral infections

25. Immunogenicity of Pfizer mRNA COVID-19 vaccination followed by J&J adenovirus COVID-19 vaccination in two CLL patients

26. Is presymptomatic spread a major contributor to COVID-19 transmission?

27. Loss of Preexisting Immunological Memory Among Human Immunodeficiency Virus–Infected Women Despite Immune Reconstitution With Antiretroviral Therapy

28. Persistence of Neutralizing Antibody Responses Among Yellow Fever Virus 17D Vaccinees Living in a Nonendemic Setting

29. Maturation of the infant rhesus macaque gut microbiome and its role in the development of diarrheal disease

30. Advanced oxidation technology for the development of a next-generation inactivated West Nile virus vaccine

31. SARS-CoV-2 specific memory B-cells from individuals with diverse disease severities recognize SARS-CoV-2 variants of concern

32. Establishment of Monoclonal Antibody Standards for Quantitative Serological Diagnosis of SARS-CoV-2 in Low-Incidence Settings

33. Longitudinal profiling of the macaque vaginal microbiome reveals similarities to diverse human vaginal communities: implications for use as a pre-clinical model for bacterial vaginosis

34. Consumptive coagulopathy of severe yellow fever occurs independently of hepatocellular tropism and massive hepatic injury

35. Polygenic prediction of atopic dermatitis improves with atopic training and filaggrin factors

36. Vaccine-mediated protection against Campylobacter -associated enteric disease

38. Protective antibodies against Eastern equine encephalitis virus bind to epitopes in domains A and B of the E2 glycoprotein

39. Reply to Heininger

40. Analysis of COVID-19 Transmission: Low Risk of Presymptomatic Spread?

41. Reply to Plotkin

42. Viral opportunistic infections in Mauritian cynomolgus macaques undergoing allogeneic stem cell transplantation mirror human transplant infectious disease complications

43. Lipid Profiles in Eczema Herpeticum and Eczema Vaccinatum Reflect Changes that Predispose to Disseminated Viral Infection

44. Inflammation Causes Resistance to Anti-CD20–Mediated B Cell Depletion

45. Alcohol intake alters immune responses and promotes CNS viral persistence in mice

46. Role of Multivalency and Antigenic Threshold in Generating Protective Antibody Responses

47. Heterogeneity and longevity of antibody memory to viruses and vaccines

48. Successful Vaccines

49. Cytokine-Mediated Activation of NK Cells during Viral Infection

50. Rat Cytomegalovirus Vaccine Prevents Accelerated Chronic Rejection in CMV-Naïve Recipients of Infected Donor Allograft Hearts